Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 1
2002 4
2003 1
2005 1
2007 1
2012 1
2013 1
2014 5
2015 1
2016 1
2018 2
2021 4
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Results by year

Filters applied: . Clear all
Page 1
Aripiprazole (Otsuka Pharmaceutical Co).
Ozdemir V, Fourie J, Ozdener F. Ozdemir V, et al. Among authors: ozdener f. Curr Opin Investig Drugs. 2002 Jan;3(1):113-20. Curr Opin Investig Drugs. 2002. PMID: 12054061 Review.
Fasidotril Eli Lilly.
Ozdener F, Ozdemir V. Ozdener F, et al. Curr Opin Investig Drugs. 2003 Sep;4(9):1113-9. Curr Opin Investig Drugs. 2003. PMID: 14582457 Review.
Evaluation of Nutritional Status and Anxiety Levels in Patients Applying to the Radiation Oncology Outpatient Clinic during the COVID-19 Pandemic: Turkish Society for Radiation Oncology Group Study (TROD 12:02).
Yurut Caloglu V, Akmansu M, Yalman D, Karabulut Gul S, Kocak Z, Arican Alicikus Z, Serarslan A, Akyurek S, Zoto Mustafayev T, Demiroz C, Colpan Oksuz D, Kanyilmaz G, Altinok P, Kaytan Saglam E, Yentek Balkanay A, Akboru H, Keven E, Yildirim B, Onal C, Igdem S, Ozkan E, Ozdener F, Caloglu M. Yurut Caloglu V, et al. Among authors: ozdener f. Nutr Cancer. 2022;74(10):3601-3610. doi: 10.1080/01635581.2022.2093386. Epub 2022 Jul 6. Nutr Cancer. 2022. PMID: 35792709
A Phase II Study of the Combination of Oxaliplatin, Capecitabine, and Trastuzumab and Chemoradiotherapy in the Adjuvant Setting in Operated Patients With HER2-positive Gastric or Gastroesophageal Junction Cancer (TOXAG Study): A Turkish Oncology Group Study.
Abali H, Yalcin S, Onal HC, Dane F, Oksuzoglu B, Ozdemir N, Mertsoylu H, Artac M, Camci C, Karabulut B, Basal FB, Budakoglu B, Sendur MAN, Goktas B, Ozdener F, Baygul A. Abali H, et al. Among authors: ozdener f. Am J Clin Oncol. 2021 Jul 1;44(7):301-307. doi: 10.1097/COC.0000000000000825. Am J Clin Oncol. 2021. PMID: 33979100 Clinical Trial.
27 results